SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Brown WD, Gilles FH, Tavaré CJ, et al. Prognostic limitations of the Daumas-Duport grading scheme in childhood supratentorial astroglial tumors. J Neuropathol Exp Neurol. 1998; 57: 10351040.
  • 2
    Gilles F, Brown W, Leviton A, et al. Limitations of the World Health Organization classification of childhood supratentorial astrocytic tumors. Cancer. 2000; 88: 14771483.
  • 3
    Gilles F, Leviton A, Tavaré C, et al. Definitive classes of childhood supratentorial neuroglial tumors. Pediatr Dev Pathol. 2000; 3: 126139.
  • 4
    Gilles FH, Sobel EL, Leviton A, Tavaré CJ, Hedley-Whyte ET. Histologic feature reliability in childhood neural tumors. J Neuropathol Exp Neurol. 1994; 53: 559571.
  • 5
    Gilles FH, Sobel EL, Leviton A, Tavaré CJ, Hedley-Whyte ET. Quantitative histologic factors for grouping childhood supratentorial neuroglial tumors. Pediatr Pathol Lab Med. 1997; 17: 729754.
  • 6
    Childhood Brain Tumor Consortium. Intraobserver reproducibility in assigning brain tumors to classes in the World Health Organization diagnostic scheme. J Neurooncol. 1989; 7: 211224.
  • 7
    Childhood Brain Tumor Consortium. A study of childhood brain tumors based on surgical biopsies from ten North American institutions: sample description. J Neurooncol. 1988; 6: 923.
  • 8
    Young JL Jr., Miller RW. Incidence of malignant tumors in US children. J Pediatr. 1975; 86: 254258.
  • 9
    Leviton A. Principles of epidemiology. In: CohenME, DuffnerPK, editors. Brain tumors in children: principles of diagnosis and treatment. New York: Raven Press, Ltd., 1994: 2749.
  • 10
    Gilles FH, Leviton A, Hedley-Whyte ET, et al. Childhood brain tumors that occupy more than one compartment at presentation. Multiple compartment tumors. J Neurooncol. 1992; 14: 4556.
  • 11
    Kowalczuk A, Macdonald RL, Amidei C, et al. Quantitative imaging study of extent of surgical resection and prognosis of malignant astrocytomas. Neurosurgery. 1997; 41: 10281036; discussion, 36–38.
  • 12
    Levin VA, Prados MR, Wara WM, et al. Radiation therapy and bromodeoxyuridine chemotherapy followed by procarbazine, lomustine, and vincristine for the treatment of anaplastic gliomas. Int J Radiat Oncol Biol Phys. 1995; 32: 7583.
  • 13
    Levin VA, Edwards MS, Wara WM, Allen J, Ortega J, Vestnys P. 5-fluorouracil and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) followed by hydroxyurea, misonidazole, and irradiation for brain stem gliomas: a pilot study of the Brain Tumor Research Center and the Childrens Cancer Group. Neurosurgery. 1984; 14: 679681.
  • 14
    Levin VA, Maor MH, Thall PF, et al. Phase II study of accelerated fractionation radiation therapy with carboplatin followed by vincristine chemotherapy for the treatment of glioblastoma multiforme. Int J Radiat Oncol Biol Phys. 1995; 33: 357364.
  • 15
    Hess KR. Extent of resection as a prognostic variable in the treatment of gliomas. J Neurooncol. 1999; 42: 227231.
  • 16
    Groves MD, Maor MH, Meyers C, et al. A phase II trial of high-dose bromodeoxyuridine with accelerated fractionation radiotherapy followed by procarbazine, lomustine, and vincristine for glioblastoma multiforme. Int J Radiat Oncol Biol Phys. 1999; 45: 127135.
  • 17
    Tooth HH. Some observations on the growth and survival period of intracranial tumours based on the review of 500 cases, with special reference to the pathology of gliomata. Brain. 1912; 35: 61108.
  • 18
    Wong ET, Hess KR, Gleason MJ, et al. Outcomes and prognostic factors in recurrent glioma patients enrolled onto phase II clinical trials. J Clin Oncol. 1999; 17: 2572.